Advertisement

May 7, 2018 Issue

09619-ofc.jpg

May 7, 2018 Cover

Volume 96, Issue 19

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

Cover:A joystick controller wired to the word CAR in the words "Controlling CAR T-cell therapy."

Credit: Yang H. Ku/C&EN/Shutterstock

Full Article
Volume 96 | Issue 19

All Issues

Quote of the Week

“Incremental research doesn’t grow the company by much.”

Ulrich Küsthardt, chief innovation officer , Evonik

Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

  • Evonik keeps the faith in long-term research

    German chemical maker seeks to balance technical support and basic R&D that can open new markets

  • Chemistry education moves from classroom to escape room

    Chemistry teachers turn to puzzle-based activity to keep high school students engaged 

  • Career Ladder: Yun He

    Opportunities in academia and industry call chemist from China to the U.S.—and back again

ADVERTISEMENT
image name
Energy Storage

New battery could serve the grid

Manganese-hydrogen design boasts high capacity, long life, and the promise of low cost

ADVERTISEMENT
ADVERTISEMENT